Skip to main navigation Skip to search Skip to main content

Lilly GZMG: (RENEW-Op-1) A Study to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Buprenorphine with or without Naloxone in Early Recovery of Participants with Opioid Use Disorder (GZMG)

Grants and Contracts Details

StatusActive
Effective start/end date5/8/265/8/28

Funding

  • Lilly USA LLC: $26,000.00